Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 5:07 PM View:  | Lorrain Daniel S. Chief Scientific Officer | Contineum Therapeutics, Inc. (CTNM) | 18-Nov-24 | Sale (Planned) | 6,190 | $16.38 | $101,421.00 | (3%) 179.66K to 173.47K | |
| 14-Aug-24 6:03 PM View: | Huhn Stephen L. CMO & Sr VP, Clinical Dev. | Contineum Therapeutics, Inc. (CTNM) | 13-Aug-24 | Option Exercise | 12,800 | $1.01 | $12,928.00 | 100% 0 to 12.8K | |
| 11-Apr-24 6:10 PM View: | Versant Venture Capital Vi,... 10% Owner | Contineum Therapeutics, Inc. (CTNM) | 09-Apr-24 | Conversion | 542,628 | -- | -- | 144% 375.54K to 918.16K |
